Table 1.
Treatments | ermB | ermF | sul1 | sul2 | sul3 | tetA | tetG | tetM | tetO | IntI1 |
---|---|---|---|---|---|---|---|---|---|---|
CT | 13.8% a | 96.2% c | 87.5% c | 93.0% c | 96.0% b | 59.3% d | 88.7% c | -- | 23.1% d | 96.9% c |
HT | 14.7% a | 96.6% b,c | 95.5% a | 97.5% b | 98.5% a | 77.2% c | 88.2% d | 42.6% | 60.0% c | 97.7% b |
HT2C | 11.0% b | 97.9% a,b | 94.8% b | 99.3% a,b | 98.4% a | 86.6% b | 93.4% a | -- | 77.9% b | 99.3% a |
HT5C | 7.9% c | 98.5% a | 95.3% a | 99.5% a | 98.8% a | 92.2% a | 91.6% b | -- | 80.1% a | 99.3% a |
The different lowercase in the table indicated significant differences between treatments at p < 0.05 level.